Drug Delivery Technology Market

The drug delivery technology market is projected to be valued at USD 52.1 billion by 2025 and is expected to reach USD 136.4 billion by 2035, registering a CAGR of 10.1% during the forecast period. Ocular route is expected to hold a 48.0% revenue share in 2025, driven by increasing prevalence of chronic and age-related eye disorders. Pharmaceutical and biotechnology companies are anticipated to dominate the end user segment with a 65.0% market share in 2025, supported by high R&D investments and accelerated adoption of advanced drug delivery platforms in clinical applications.